BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Braglia L, Zavatti M, Vinceti M, Martelli AM, Marmiroli S. Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target? Biochim Biophys Acta Mol Cell Res 2020;1867:118731. [PMID: 32360668 DOI: 10.1016/j.bbamcr.2020.118731] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 18.0] [Reference Citation Analysis]
Number Citing Articles
1 Noser AA, Abdelmonsef AH, Salem MM. Design, Synthesis and Molecular docking of novel substituted azepines as inhibitors of PI3K/Akt/TSC2/mTOR signaling pathway in colorectal carcinoma. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.106299] [Reference Citation Analysis]
2 Ma X, Sun X, Wang R, Guo Y, Xu M. Effects of curcumin on 5-fluorouracil resistance of colon cancer cells through the PI3K/AKT/mTOR pathway via MACC1. European Journal of Integrative Medicine 2022;56:102202. [DOI: 10.1016/j.eujim.2022.102202] [Reference Citation Analysis]
3 Zhao X, Zhang X, Ali Sheikh MS. DNA Methyltransferase Inhibitor 5-AZA-DC Regulates TGFβ1-Mediated Alteration of Neuroglial Cell Functions after Oxidative Stress. Oxidative Medicine and Cellular Longevity 2022;2022:1-13. [DOI: 10.1155/2022/9259465] [Reference Citation Analysis]
4 Ma X, Ren H, Zhang Y, Wang B, Ma H. LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway. Environ Toxicol 2022. [PMID: 36125241 DOI: 10.1002/tox.23656] [Reference Citation Analysis]
5 Fan Y, Zhang X, Tong Y, Chen S, Liang J. Curcumin against gastrointestinal cancer: A review of the pharmacological mechanisms underlying its antitumor activity. Front Pharmacol 2022;13:990475. [DOI: 10.3389/fphar.2022.990475] [Reference Citation Analysis]
6 Al-khfajy WS, Arif IS, Al-sudani BT. Synergistic effect of obeticholic acid and fasting-mimicking on proliferative, migration, and survival signaling in prostate cancer. PHAR 2022;69:579-587. [DOI: 10.3897/pharmacia.69.e81452] [Reference Citation Analysis]
7 Choudhury AD. PTEN-PI3K pathway alterations in advanced prostate cancer and clinical implications. Prostate 2022;82 Suppl 1:S60-72. [PMID: 35657152 DOI: 10.1002/pros.24372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Aggarwal S, Bhadana K, Singh B, Rawat M, Mohammad T, Al-keridis LA, Alshammari N, Hassan MI, Das SN. Cinnamomum zeylanicum Extract and its Bioactive Component Cinnamaldehyde Show Anti-Tumor Effects via Inhibition of Multiple Cellular Pathways. Front Pharmacol 2022;13:918479. [DOI: 10.3389/fphar.2022.918479] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Estaras M, Martinez R, García A, Ortiz-placin C, Iovanna JL, Santofimia-castaño P, Gonzalez A. Melatonin modulates metabolic adaptation of pancreatic stellate cells subjected to hypoxia. Biochemical Pharmacology 2022. [DOI: 10.1016/j.bcp.2022.115118] [Reference Citation Analysis]
10 Resurreccion EP, Fong K. The Integration of Metabolomics with Other Omics: Insights into Understanding Prostate Cancer. Metabolites 2022;12:488. [DOI: 10.3390/metabo12060488] [Reference Citation Analysis]
11 Qin X, Liu M, Xu C, Xing B, Xu X, Wu Y, Ding H, Zhao Q. ZDQ-0620, a Novel Phosphatidylinositol 3-Kinase Inhibitor, Inhibits Colorectal Carcinoma Cell Proliferation and Suppresses Angiogenesis by Attenuating PI3K/AKT/mTOR Pathway. Front Oncol 2022;12:848952. [PMID: 35311154 DOI: 10.3389/fonc.2022.848952] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Ashrafizadeh M, Paskeh MDA, Mirzaei S, Gholami MH, Zarrabi A, Hashemi F, Hushmandi K, Hashemi M, Nabavi N, Crea F, Ren J, Klionsky DJ, Kumar AP, Wang Y. Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response. J Exp Clin Cancer Res 2022;41:105. [PMID: 35317831 DOI: 10.1186/s13046-022-02293-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 17.0] [Reference Citation Analysis]
13 Wang L, Guo Z, Guo B, Gao F, Liu X, Xu Y, Wang Y, Jain DK. CircNR3C1 Alleviates Gastric Cancer Development by Inactivating AKT/mTOR. Journal of Healthcare Engineering 2022;2022:1-6. [DOI: 10.1155/2022/8402732] [Reference Citation Analysis]
14 Ai J, Li J, Su Q, Ma H, Wei Q, Li H, Gao G. rAAV-delivered PTEN therapeutics for prostate cancer. Mol Ther Nucleic Acids 2022;27:122-32. [PMID: 34976432 DOI: 10.1016/j.omtn.2021.11.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Almajali B, Johan MF, Al-wajeeh AS, Wan Taib WR, Ismail I, Alhawamdeh M, Al-tawarah NM, Ibrahim WN, Al-rawashde FA, Al-jamal HAN. Gene Expression Profiling and Protein Analysis Reveal Suppression of the C-Myc Oncogene and Inhibition JAK/STAT and PI3K/AKT/mTOR Signaling by Thymoquinone in Acute Myeloid Leukemia Cells. Pharmaceuticals 2022;15:307. [DOI: 10.3390/ph15030307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Li S, Chen L. Exosomes in Pathogenesis, Diagnosis, and Treatment of Hepatocellular Carcinoma. Front Oncol 2022;12:793432. [PMID: 35155236 DOI: 10.3389/fonc.2022.793432] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Wang P, Hu Y, Qu P, Zhao Y, Liu J, Zhao J, Kong B. Protein tyrosine phosphatase receptor type Z1 inhibits the cisplatin resistance of ovarian cancer by regulating PI3K/AKT/mTOR signal pathway. Bioengineered 2022;13:1931-41. [PMID: 35001804 DOI: 10.1080/21655979.2021.2022268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Iqubal A, Haque SE. Molecular Mechanism of Oxidative Stress in Cancer and Its Therapeutics. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2022. [DOI: 10.1007/978-981-16-1247-3_150-1] [Reference Citation Analysis]
19 Iqubal A, Haque SE. Molecular Mechanism of Oxidative Stress in Cancer and Its Therapeutics. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2022. [DOI: 10.1007/978-981-16-5422-0_150] [Reference Citation Analysis]
20 Chen L, Guo Y, Wu Z, Zhao S, Zhang Z, Zheng F, Sun L, Hao Z, Xu C, Wang T, Peng Y. Epicatechin gallate prevents the de novo synthesis of fatty acid and the migration of prostate cancer cells. Acta Biochim Biophys Sin (Shanghai) 2021;53:1662-9. [PMID: 34718375 DOI: 10.1093/abbs/gmab144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Thiemeyer H, Taher L, Schille JT, Packeiser EM, Harder LK, Hewicker-Trautwein M, Brenig B, Schütz E, Beck J, Nolte I, Murua Escobar H. An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes. Int J Mol Sci 2021;22:11481. [PMID: 34768937 DOI: 10.3390/ijms222111481] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
22 Gordon MT, Ziemba BP, Falke JJ. Single-molecule studies reveal regulatory interactions between master kinases PDK1, AKT1, and PKC. Biophys J 2021:S0006-3495(21)00874-2. [PMID: 34673053 DOI: 10.1016/j.bpj.2021.10.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
23 Pungsrinont T, Kallenbach J, Baniahmad A. Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer. Int J Mol Sci 2021;22:11088. [PMID: 34681745 DOI: 10.3390/ijms222011088] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
24 Rigotto G, Montini B, Mattiolo A, Lazzari N, Piano MA, Remondini D, Marmiroli S, Bertacchini J, Chieco-Bianchi L, Calabrò ML. Mechanisms Involved in the Promoting Activity of Fibroblasts in HTLV-1-Mediated Lymphomagenesis: Insights into the Plasticity of Lymphomatous Cells. Int J Mol Sci 2021;22:10562. [PMID: 34638901 DOI: 10.3390/ijms221910562] [Reference Citation Analysis]
25 Darici S, Zavatti M, Braglia L, Accordi B, Serafin V, Horne GA, Manzoli L, Palumbo C, Huang X, Jørgensen HG, Marmiroli S. Synergistic cytotoxicity of dual PI3K/mTOR and FLT3 inhibition in FLT3-ITD AML cells. Adv Biol Regul 2021;82:100830. [PMID: 34555701 DOI: 10.1016/j.jbior.2021.100830] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
26 Nishimura Y, Yamakawa D, Uchida K, Shiromizu T, Watanabe M, Inagaki M. Primary cilia and lipid raft dynamics. Open Biol 2021;11:210130. [PMID: 34428960 DOI: 10.1098/rsob.210130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Zhang X, Lu Z, Ren X, Chen X, Zhou X, Zhou X, Zhang T, Liu Y, Wang S, Qin C. Genetic comprehension of organophosphate flame retardants, an emerging threat to prostate cancer. Ecotoxicol Environ Saf 2021;223:112589. [PMID: 34358932 DOI: 10.1016/j.ecoenv.2021.112589] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
28 Xie J, Kusnadi EP, Furic L, Selth LA. Regulation of mRNA Translation by Hormone Receptors in Breast and Prostate Cancer. Cancers (Basel) 2021;13:3254. [PMID: 34209750 DOI: 10.3390/cancers13133254] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
29 Gordon MT, Ziemba BP, Falke JJ. Single Molecule Studies and Kinase Activity Measurements Reveal Regulatory Interactions between the Master Kinases Phosphoinositide-Dependent-Kinase-1 (PDK1), Protein Kinase B (AKT1/PKB) and Protein Kinase C (PKCα).. [DOI: 10.1101/2021.06.25.449974] [Reference Citation Analysis]
30 Ferrari E, Naponelli V, Bettuzzi S. Lemur Tyrosine Kinases and Prostate Cancer: A Literature Review. Int J Mol Sci 2021;22:5453. [PMID: 34064250 DOI: 10.3390/ijms22115453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Cui Z, Gao H, Yan N, Dai Y, Wang H, Wang M, Wang J, Zhang D, Sun P, Qi T, Wang Q, Kang W, Jin X. LncRNA PlncRNA-1 accelerates the progression of prostate cancer by regulating PTEN/Akt axis. Aging (Albany NY) 2021;13:12113-28. [PMID: 33848262 DOI: 10.18632/aging.202919] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
32 Kvízová J, Pavlíčková V, Kmoníčková E, Ruml T, Rimpelová S. Quo Vadis Advanced Prostate Cancer Therapy? Novel Treatment Perspectives and Possible Future Directions. Molecules 2021;26:2228. [PMID: 33921501 DOI: 10.3390/molecules26082228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Wu YP, Ke ZB, Zheng WC, Chen YH, Zhu JM, Lin F, Li XD, Chen SH, Cai H, Zheng QS, Wei Y, Xue XY, Xu N. Kinesin family member 18B regulates the proliferation and invasion of human prostate cancer cells. Cell Death Dis 2021;12:302. [PMID: 33753726 DOI: 10.1038/s41419-021-03582-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
34 Abadi AJ, Zarrabi A, Gholami MH, Mirzaei S, Hashemi F, Zabolian A, Entezari M, Hushmandi K, Ashrafizadeh M, Khan H, Kumar AP. Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers. Biomolecules 2021;11:304. [PMID: 33670518 DOI: 10.3390/biom11020304] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 21.0] [Reference Citation Analysis]
35 Samaržija I. Post-Translational Modifications That Drive Prostate Cancer Progression. Biomolecules 2021;11:247. [PMID: 33572160 DOI: 10.3390/biom11020247] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
36 Wengner AM, Scholz A, Haendler B. Targeting DNA Damage Response in Prostate and Breast Cancer. Int J Mol Sci 2020;21:E8273. [PMID: 33158305 DOI: 10.3390/ijms21218273] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
37 Fusco N, Sajjadi E, Venetis K, Gaudioso G, Lopez G, Corti C, Rocco EG, Criscitiello C, Malapelle U, Invernizzi M. PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine? Genes (Basel) 2020;11:E719. [PMID: 32605290 DOI: 10.3390/genes11070719] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 15.0] [Reference Citation Analysis]